Shanghai Genechem Co., Ltd. announced that it has received CNY 100,000,000 in a round of funding in January 2016. The transaction included participation from investors including HighLight Capital, China Renaissance Partners, Investment Arm, and returning investor Jiangsu Aoyang Health Industry Co.ltd. (SZSE:002172)
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.53 CNY | +0.40% |
|
0.00% | -33.25% |
1st Jan change | Capi. | |
---|---|---|
-33.25% | 267M | |
+3.94% | 3.06B | |
-2.01% | 1.19B | |
-41.64% | 1.03B | |
+18.72% | 951M | |
+7.72% | 829M | |
+9.60% | 807M | |
-29.75% | 694M | |
+39.36% | 541M | |
+16.77% | 541M |
- Stock Market
- Equities
- 002172 Stock
- News Jiangsu Aoyang Health Industry Co.ltd.
- Shanghai Genechem Co., Ltd. announced that it has received CNY 100 million in funding from HighLight Capital, China Renaissance Partners, Investment Arm, Jiangsu Aoyang Health Industry Co.ltd. and other investors